New Evidence is a third-party publication providing oncology specialists with scientific data from research presented at international and Canadian oncology conferences.A special feature of the journal, the Canadian perspective, gives key opinion leaders a forum to discuss recent developments in oncology and to comment on how these advances may shape Canadian clinical practice. In addition, the investigator commentary sections provide information on key clinical studies from interviews with principal investigators. New Evidence also publishes discussion and expert opinion papers on timely topics of interest to oncologists in Canada.

Our September 2011 issue presents coverage from the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Chicago, Illinois from June 3–7, 2011. The issue examines key studies in metastatic melanoma, hematology and ovarian cancer aimed at improving patient care, particularly in the era of personalized medicine. We would like to thank Dr. Silvy Lachance and Dr. Teresa Petrella for their Canadian perspectives.

We invite you to join us to receive the print version of New Evidence. Visit our website often for more reports on current research, downloadable slide presentations on various topics, and future online issues of our journal.